A randomised controlled trial of nasal constant positive airway pressure (NCPAP) as primary therapy for respiratory distress syndrome (RDS) in very pre-term infants.
2013 ◽
Vol 98
(Suppl 1)
◽
pp. A78-A78
◽
2015 ◽
Vol 3
(S1)
◽
2000 ◽
Vol 82
(1)
◽
pp. F14-F18
◽